Navigation Links
The NeoStrata Company Appoints a New Vice President of Operations
Date:9/17/2007

PRINCETON, N.J., Sept. 17 /PRNewswire/ -- The NeoStrata Company, Inc. announced today the appointment of Peter Crisafulli to the position of Vice President of Operations. In his new role, Mr. Crisafulli will support the continued growth of NeoStrata's existing brands, both domestically and in more than 70 countries around the world.

"I'm thrilled to be joining the wonderful people of NeoStrata at this exciting time in the company's life," said Mr. Crisafulli, "I look forward to helping them meet all their growth needs across all their markets."

Mr. Crisafulli joins The NeoStrata Company, Inc. with many years of senior management experience in the pharmaceutical and personal care industries. Most recently, he had been consulting for Johnson & Johnson. Previously, he spent fourteen years in ever increasing operation positions at Revlon rising to be their Vice President of International Operations. His prior experience also includes sixteen years with Ciba-Geigy, including time as their Vice President of Manufacturing. Mr. Crisafulli brings a strong track record of manufacturing and operational excellence which should truly help facilitate NeoStrata's domestic and international growth.

Mr. Crisafulli holds a B.S. degree in Industrial Engineering from the New Jersey Institute of Technology, and an MBA from Seton Hall University.

About The NeoStrata Company, Inc.

The NeoStrata Company is a privately held, research-based company located in Princeton, New Jersey. It was founded in 1988 by leading dermatological researchers and inventors, Ruey J.Yu, Ph.D., O.M.D., and dermatologist Eugene J. Van Scott, M.D., who are widely recognized as the pioneers of alpha-hydroxy acid (AHA) technology. Today, NeoStrata continues to develop and to license its extensive portfolio of patented technology including polyhydroxy acids (PHAs) and the bionic acids, as well as novel N-acetyl amino sugars and N-acetyl amino acids for cosmetic, OTC and Rx applications. NeoStrata also markets globally its own comprehensive lines of skincare brands, including NeoStrata, Exuviance and CoverBlend; and, has recently initiated its first clinical studies for prescription dermatologicals.


'/>"/>
SOURCE The NeoStrata Company, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medicis Pharmaceutical company enters pediatric market
2. Problems Of a Growing Company
3. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
4. British company developing ‘Safer Cigarettes
5. Australian Company Gets $10 million For Developing Skin Cancer Gel
6. Elderly People Prefer The Company Of Pet Dogs
7. Ossur Acquires the U.S. Orthopaedics Company
8. Britain Approves Indian Company For Supplying Medicines
9. Drug Company Admits Knowledge Of Side Effects In Monkeys
10. Ranbaxy Expands By Acquiring A Generic Company In Belgium
11. Indian Training Company To Train Children In Dubai, Sharjah
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , ... March 24, 2017 , ... ... which will spark a conversation on the current obstacles facing infection prevention and ... completely preventable deaths caused by these infections. , The print component of ...
(Date:3/24/2017)... ... ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the opening ... is the group’s 7th location in San Antonio and 23rd in Texas. Dr. ... from the clinic, which opened March 22, 2017. , The team of ...
(Date:3/24/2017)... Pittsburgh, PA (PRWEB) , ... March 24, 2017 ... ... the Oncology Nursing Society (ONS) wanted to create a communications platform that positions ... realize this goal, Elliance and ONS reinvented their online publication as an always-on, ...
(Date:3/24/2017)... ... 24, 2017 , ... Gastro Health (“GH”) ( http://www.gastrohealth.com ... for colonoscopy at the HyGIeaCare® Center that is to be located adjacent to ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration (FDA), ...
(Date:3/24/2017)... ... 24, 2017 , ... “Vintage and Harvest A Cultivation of Christian Love” is ... residing in North Carolina with his wife, Anna Marie. He and his wife are ... David is also the author of “Shadow and Substance.” , “Love, the agape kind, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 24, 2017  Eli Lilly and Company (NYSE: ... invest $850 million in its U.S. operations in ... U.S. enterprise, including research laboratories, manufacturing sites, and ... driven by demand for Lilly products, as well ... development targeting cancer, pain, diabetes and other unmet ...
(Date:3/24/2017)... YORK and GENEVA , ... announced on World Tuberculosis Day revitalizes efforts to develop ... On World Tuberculosis Day, TB Alliance and ... for the clinical development of sutezolid, an antibiotic drug ... sublicense pertains to the development of sutezolid in combination ...
(Date:3/23/2017)... PUNE, India , March 23, 2017 ... are growing ageing population, increasing diabetic population, accelerating economic growth ... developments of this industry are higher life expectancy of ESRD ... potential in emerging markets. However, the expansion of the market ... ...
Breaking Medicine Technology: